Advances in the Discovery of Novel Inhaled PI3Kδ Inhibitors for the Treatment of Asthma.
Sign Up to like & getrecommendations! Published in 2022 at "Current medicinal chemistry"
DOI: 10.2174/0929867329666220819115011
Abstract: Bronchial asthma is the most common chronic respiratory illness, the incidence of which continues to increase annually. Currently, effective treatments for CS-resistant asthma and severe asthma are still lacking, and new therapeutic regimens are urgently… read more here.
Keywords: pi3k; discovery novel; inhaled pi3k; asthma ... See more keywords